View in EDS PDF Full Text

Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.

Saved in:
Bibliographic Details
Title: Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
Authors: Bourafai-Aziez A; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France., Benabderrahmane M; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France., Paysant H; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France., Weiswald LB; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France., Poulain L; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France., Carlier L; Sorbonne Université, École Normale Supérieure, PSL University, CNRS, Laboratoire des Biomolécules, LBM, Paris, France., Ravault D; Sorbonne Université, École Normale Supérieure, PSL University, CNRS, Laboratoire des Biomolécules, LBM, Paris, France., Jouanne M; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France., Coadou G; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France., Oulyadi H; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France., Voisin-Chiret AS; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France., Sopková-de Oliveira Santos J; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France., Sebban M; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France.
Source: Drug design, development and therapy [Drug Des Devel Ther] 2021 Dec 15; Vol. 15, pp. 5035-5059. Date of Electronic Publication: 2021 Dec 15 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34949914
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bourafai-Aziez+A%22">Bourafai-Aziez A</searchLink>; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France.<br /><searchLink fieldCode="AU" term="%22Benabderrahmane+M%22">Benabderrahmane M</searchLink>; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France.<br /><searchLink fieldCode="AU" term="%22Paysant+H%22">Paysant H</searchLink>; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.<br /><searchLink fieldCode="AU" term="%22Weiswald+LB%22">Weiswald LB</searchLink>; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.<br /><searchLink fieldCode="AU" term="%22Poulain+L%22">Poulain L</searchLink>; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, Caen, 14076, France.<br /><searchLink fieldCode="AU" term="%22Carlier+L%22">Carlier L</searchLink>; Sorbonne Université, École Normale Supérieure, PSL University, CNRS, Laboratoire des Biomolécules, LBM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ravault+D%22">Ravault D</searchLink>; Sorbonne Université, École Normale Supérieure, PSL University, CNRS, Laboratoire des Biomolécules, LBM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Jouanne+M%22">Jouanne M</searchLink>; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France.<br /><searchLink fieldCode="AU" term="%22Coadou+G%22">Coadou G</searchLink>; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France.<br /><searchLink fieldCode="AU" term="%22Oulyadi+H%22">Oulyadi H</searchLink>; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France.<br /><searchLink fieldCode="AU" term="%22Voisin-Chiret+AS%22">Voisin-Chiret AS</searchLink>; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France.<br /><searchLink fieldCode="AU" term="%22Sopková-de+Oliveira+Santos+J%22">Sopková-de Oliveira Santos J</searchLink>; Normandie Univ, UNICAEN, CERMN, Caen, 14000, France.<br /><searchLink fieldCode="AU" term="%22Sebban+M%22">Sebban M</searchLink>; Normandie Université, UNIROUEN, INSA de Rouen, CNRS Laboratoire COBRA (UMR 6014 & FR 3038), Rouen, 76000, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101475745%22">Drug design, development and therapy</searchLink> [Drug Des Devel Ther] 2021 Dec 15; Vol. 15, pp. 5035-5059. <i>Date of Electronic Publication: </i>2021 Dec 15 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press+Limited%22">Dove Press Limited </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101475745 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1177-8881 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211778881%22">11778881 </searchLink><i>NLM ISO Abbreviation: </i>Drug Des Devel Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34949914
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/DDDT.S323077
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5035
    Titles:
      – TitleFull: Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bourafai-Aziez A
      – PersonEntity:
          Name:
            NameFull: Benabderrahmane M
      – PersonEntity:
          Name:
            NameFull: Paysant H
      – PersonEntity:
          Name:
            NameFull: Weiswald LB
      – PersonEntity:
          Name:
            NameFull: Poulain L
      – PersonEntity:
          Name:
            NameFull: Carlier L
      – PersonEntity:
          Name:
            NameFull: Ravault D
      – PersonEntity:
          Name:
            NameFull: Jouanne M
      – PersonEntity:
          Name:
            NameFull: Coadou G
      – PersonEntity:
          Name:
            NameFull: Oulyadi H
      – PersonEntity:
          Name:
            NameFull: Voisin-Chiret AS
      – PersonEntity:
          Name:
            NameFull: Sopková-de Oliveira Santos J
      – PersonEntity:
          Name:
            NameFull: Sebban M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 12
              Text: 2021 Dec 15
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1177-8881
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Drug design, development and therapy
              Type: main
ResultId 1